查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1566825

外部鼻扩张器市场：按应用、按最终用户、按分销管道：2024-2033 年全球机会分析和产业预测

External Nasal Dilator Market By Application (Snoring, Sleep apnea, Nasal congestion, Others) , By End User (Adults, Pediatric) By Distribution Channel (Offline, Online) : Global Opportunity Analysis and Industry Forecast, 2024-2033
出版日期: | 出版商: Allied Market Research | 英文 280 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2023年，全球外鼻孔扩张器市值为9,830万美元，预计2024年至2033年复合年增长率为5.1%，到2033年达到1.624亿美元。

外鼻扩张器是一种创新设备，旨在透过从外部轻轻打开鼻腔来增加鼻腔内的气流。该设备对于患有睡眠呼吸中止症、鼻塞、打鼾或想要在运动期间改善呼吸的人特别有益。外鼻孔扩张器旨在缓解气流限制，从而改善呼吸和整体健康。

全球外鼻孔扩张器市场的成长是由于睡眠呼吸中止症盛行率急剧上升，以及因鼻塞、打鼾或运动而想要改善呼吸的人越来越受欢迎和采用外鼻孔扩张器。驱动的，例如：此外，过敏、感冒、鼻窦和解剖异常也是鼻塞的主要原因。因此，鼻扩张器描述了一种透过扩张鼻道来缓解鼻塞并促进更好的气流和呼吸的非侵入性方法。此外，为了监测呼吸模式、睡眠品质和其他指标，某些外鼻孔扩张器结合了感测器或网路元件，符合穿戴式健康技术的发展趋势。因此，最终用户可以从这些资料中进一步了解他们的整体呼吸健康状况和鼻腔气流。

然而，这些扩展器的成本和可用性正在阻碍市场成长。同时，技术进步、睡眠呼吸中止症和打鼾盛行率的增加预计将推动外鼻扩张器市场的机会。例如，全球医疗设备製造商 Rhinomed 改善鼻腔给药、睡眠品质、上呼吸道疾病诊断和呼吸。透过将透过鼻子的气流平均增加 38%，MuteTM 可以减少打鼾的频率和强度，并改善您早晨的精神状态。使用者试验表明，打鼾者可以安心入睡，因为他们知道自己正在改善伴侣的睡眠品质和自己的呼吸品质。

细分概述

外鼻扩张器市场分为应用、最终用户、分销管道和区域。根据应用，市场分为打鼾、睡眠呼吸中止症、鼻塞等。依最终使用者分为成人和儿童。依分销管道分为线上通路和线下通路。从区域来看，分析涵盖北美、欧洲、亚太地区和拉丁美洲/中东/非洲。

竞品分析

报告可以客製化（可能需要额外费用和时间，请联络您的销售负责人以了解详细资讯）。

  • 国家、区域和全球各级的患者/流行病学资料
  • 监管指引
  • 根据客户兴趣新增其他公司简介
  • 按国家或地区进行的附加分析 – 市场规模和预测
  • 扩大公司简介列表
  • 历史市场资料
  • SWOT分析

目录

第一章简介

第 2 章执行摘要

第三章 市场状况

  • 市场定义和范围
  • 主要发现
    • 关键投资机会
    • 关键成功策略
  • 波特五力分析
  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会

第四章 外鼻扩张器市场：依应用分类

  • 市场概况
  • 鼾
  • 睡眠呼吸中止症
  • 鼻塞
  • 其他的

第五章 外鼻扩张器市场：依最终使用者分类

  • 市场概况
  • 成人
  • 儿科的

第六章 外鼻扩张器市场：依通路

  • 市场概况
  • 离线
  • 在线的

第七章 外鼻扩张器市场：依地区

  • 市场概况
  • 北美洲
    • 主要市场趋势和机会
    • 美国外鼻孔扩张器市场
    • 加拿大外鼻扩张器市场
    • 墨西哥外鼻扩张器市场
  • 欧洲
    • 主要市场趋势和机会
    • 法国外鼻孔扩张器市场
    • 德国外鼻孔扩张器市场
    • 义大利外鼻孔扩张器市场
    • 西班牙外鼻孔扩张器市场
    • 英国外鼻孔扩张器市场
    • 其他欧洲外鼻扩张器市场
  • 亚太地区
    • 主要市场趋势和机会
    • 中国外鼻孔扩张器市场
    • 日本外鼻孔扩张器市场
    • 印度鼻外扩张器市场
    • 韩国外鼻孔扩张器市场
    • 澳洲外鼻孔扩张器市场
    • 其他亚太地区鼻外扩张器市场
  • 拉丁美洲/中东/非洲
    • 主要市场趋势和机会
    • 巴西外鼻扩张器市场
    • 南非外鼻扩张器市场
    • 沙乌地阿拉伯外鼻扩张器市场
    • 其他拉丁美洲/中东/非洲外鼻扩张器市场

第八章 竞争格局

  • 介绍
  • 关键成功策略
  • 10家主要企业产品图谱
  • 竞争对手仪表板
  • 竞争热图
  • 主要企业定位（2023年）

第九章 公司简介

  • GlaxoSmithKline Plc
  • HealthRight Products LLC
  • Zhongshan Hongze Medical Technology Co., Ltd.
  • Permira IP Limited
  • Health Right Products LLC
  • AirWare Labs
  • Splintek Inc
  • Scandinavian Formulas
  • Tomed GmbH
  • Rhinomed Limited
简介目录
Product Code: A42161

The global external nasal dilator market was valued at $98.3 million in 2023, and is projected to reach $162.4 million by 2033, growing at a CAGR of 5.1% from 2024 to 2033.

An external nasal dilator is an innovative device designed to enhance the nasal airflow by gently opening the nasal passages from the outside. This device is especially beneficial for people who have sleep apnea, nasal congestion, snoring, or who want to breathe better when exercising. An external nasal dilator is designed to alleviate airflow constraints to improve breathing and general health.

The growth of the global external nasal dilator market is driven by several factors such as surge in the prevalence of sleep apnea, increasing popularity and adoption of external nasal dilators for, nasal congestion, snoring, or who want to breathe better when exercising. In addition, allergies, colds, sinusitis, and anatomical anomalies are major causes of nasal congestion. Thus, by enlarging the nasal passageways, external nasal dilators provide a non-invasive way to relieve nasal congestion and facilitate better airflow and breathing. Furthermore, to monitor breathing patterns, sleep quality, and other metrics, certain external nasal dilators are incorporating sensors or networking elements in line with the growing trend of wearable health technology. Thus, end users can learn more about their overall respiratory health and nasal airflow from this data.

However, cost and accessibility of these dilators hinder the growth of the market. On the other hand, technological advancements, increasing prevalence of sleep apnea, snoring is expected to drive the external nasal dilator market opportunity. For instance, the global medical device manufacturer Rhinomed improves nasal medication administration, sleep quality, upper respiratory disease diagnostics, and respiration. By increasing airflow through the nose by 38% on average, MuteTM can lessen the frequency and intensity of snoring and improve both of your morning feelings of refreshment. According to user trials, snorers can sleep easily knowing that they're enhancing both the quality of their partner's sleep and their own breathing.

Segmentation Overview

The external nasal dilator market is segmented into application, end user, distribution channel, and region. Depending on the application, the market is divided into snoring, sleep apnea, nasal congestion, and others. As per end user, it is bifurcated into adults and pediatric. According to distribution channel, the market is classified into online channel and offline channel. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Competitive Analysis

The major players operating in the external nasal dilator industry include GlaxoSmithKline Plc, HealthRight Products LLC, and Zhongshan Hongze Medical Technology Co., Ltd. Other players in the market are Permira I.P Limited, Health Right Products LLC, AirWare Labs., ?Splintek Inc, Scandinavian Formulas, Tomed GmbH, Creganna, Nasilator, Hubei YJT Technology Co., Ltd, Rhinomed Limited, Nasilator, Nasanita, ?SHREYAAS HEALTH CARE PVT LTD., and Walgreen Co. These companies have been active in adopting different tactics to maintain their position in the competitive market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Patient/epidemiology data at country, region, global level
  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • SWOT Analysis

Key Market Segments

By Application

  • Snoring
  • Sleep apnea
  • Nasal congestion
  • Others

By End User

  • Adults
  • Pediatric

By Distribution Channel

  • Offline
  • Online

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • UK
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Saudi Arabia
    • Rest of LAMEA

Key Market Players:

    • GlaxoSmithKline Plc
    • HealthRight Products LLC
    • Zhongshan Hongze Medical Technology Co., Ltd.
    • Permira I.P Limited
    • Health Right Products LLC
    • AirWare Labs
    • Splintek Inc
    • Scandinavian Formulas
    • Tomed GmbH
    • Rhinomed Limited

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: EXTERNAL NASAL DILATOR MARKET, BY APPLICATION

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Application
  • 4.2. Snoring
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Sleep Apnea
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country
  • 4.4. Nasal Congestion
    • 4.4.1. Key Market Trends, Growth Factors and Opportunities
    • 4.4.2. Market Size and Forecast, By Region
    • 4.4.3. Market Share Analysis, By Country
  • 4.5. Others
    • 4.5.1. Key Market Trends, Growth Factors and Opportunities
    • 4.5.2. Market Size and Forecast, By Region
    • 4.5.3. Market Share Analysis, By Country

CHAPTER 5: EXTERNAL NASAL DILATOR MARKET, BY END USER

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By End User
  • 5.2. Adults
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Pediatric
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country

CHAPTER 6: EXTERNAL NASAL DILATOR MARKET, BY DISTRIBUTION CHANNEL

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By Distribution Channel
  • 6.2. offline
    • 6.2.1. Key Market Trends, Growth Factors and Opportunities
    • 6.2.2. Market Size and Forecast, By Region
    • 6.2.3. Market Share Analysis, By Country
  • 6.3. Online
    • 6.3.1. Key Market Trends, Growth Factors and Opportunities
    • 6.3.2. Market Size and Forecast, By Region
    • 6.3.3. Market Share Analysis, By Country

CHAPTER 7: EXTERNAL NASAL DILATOR MARKET, BY REGION

  • 7.1. Market Overview
    • 7.1.1 Market Size and Forecast, By Region
  • 7.2. North America
    • 7.2.1. Key Market Trends and Opportunities
    • 7.2.2. Market Size and Forecast, By Application
    • 7.2.3. Market Size and Forecast, By End User
    • 7.2.4. Market Size and Forecast, By Distribution Channel
    • 7.2.5. Market Size and Forecast, By Country
    • 7.2.6. U.S. External Nasal Dilator Market
      • 7.2.6.1. Market Size and Forecast, By Application
      • 7.2.6.2. Market Size and Forecast, By End User
      • 7.2.6.3. Market Size and Forecast, By Distribution Channel
    • 7.2.7. Canada External Nasal Dilator Market
      • 7.2.7.1. Market Size and Forecast, By Application
      • 7.2.7.2. Market Size and Forecast, By End User
      • 7.2.7.3. Market Size and Forecast, By Distribution Channel
    • 7.2.8. Mexico External Nasal Dilator Market
      • 7.2.8.1. Market Size and Forecast, By Application
      • 7.2.8.2. Market Size and Forecast, By End User
      • 7.2.8.3. Market Size and Forecast, By Distribution Channel
  • 7.3. Europe
    • 7.3.1. Key Market Trends and Opportunities
    • 7.3.2. Market Size and Forecast, By Application
    • 7.3.3. Market Size and Forecast, By End User
    • 7.3.4. Market Size and Forecast, By Distribution Channel
    • 7.3.5. Market Size and Forecast, By Country
    • 7.3.6. France External Nasal Dilator Market
      • 7.3.6.1. Market Size and Forecast, By Application
      • 7.3.6.2. Market Size and Forecast, By End User
      • 7.3.6.3. Market Size and Forecast, By Distribution Channel
    • 7.3.7. Germany External Nasal Dilator Market
      • 7.3.7.1. Market Size and Forecast, By Application
      • 7.3.7.2. Market Size and Forecast, By End User
      • 7.3.7.3. Market Size and Forecast, By Distribution Channel
    • 7.3.8. Italy External Nasal Dilator Market
      • 7.3.8.1. Market Size and Forecast, By Application
      • 7.3.8.2. Market Size and Forecast, By End User
      • 7.3.8.3. Market Size and Forecast, By Distribution Channel
    • 7.3.9. Spain External Nasal Dilator Market
      • 7.3.9.1. Market Size and Forecast, By Application
      • 7.3.9.2. Market Size and Forecast, By End User
      • 7.3.9.3. Market Size and Forecast, By Distribution Channel
    • 7.3.10. UK External Nasal Dilator Market
      • 7.3.10.1. Market Size and Forecast, By Application
      • 7.3.10.2. Market Size and Forecast, By End User
      • 7.3.10.3. Market Size and Forecast, By Distribution Channel
    • 7.3.11. Rest of Europe External Nasal Dilator Market
      • 7.3.11.1. Market Size and Forecast, By Application
      • 7.3.11.2. Market Size and Forecast, By End User
      • 7.3.11.3. Market Size and Forecast, By Distribution Channel
  • 7.4. Asia-Pacific
    • 7.4.1. Key Market Trends and Opportunities
    • 7.4.2. Market Size and Forecast, By Application
    • 7.4.3. Market Size and Forecast, By End User
    • 7.4.4. Market Size and Forecast, By Distribution Channel
    • 7.4.5. Market Size and Forecast, By Country
    • 7.4.6. China External Nasal Dilator Market
      • 7.4.6.1. Market Size and Forecast, By Application
      • 7.4.6.2. Market Size and Forecast, By End User
      • 7.4.6.3. Market Size and Forecast, By Distribution Channel
    • 7.4.7. Japan External Nasal Dilator Market
      • 7.4.7.1. Market Size and Forecast, By Application
      • 7.4.7.2. Market Size and Forecast, By End User
      • 7.4.7.3. Market Size and Forecast, By Distribution Channel
    • 7.4.8. India External Nasal Dilator Market
      • 7.4.8.1. Market Size and Forecast, By Application
      • 7.4.8.2. Market Size and Forecast, By End User
      • 7.4.8.3. Market Size and Forecast, By Distribution Channel
    • 7.4.9. South Korea External Nasal Dilator Market
      • 7.4.9.1. Market Size and Forecast, By Application
      • 7.4.9.2. Market Size and Forecast, By End User
      • 7.4.9.3. Market Size and Forecast, By Distribution Channel
    • 7.4.10. Australia External Nasal Dilator Market
      • 7.4.10.1. Market Size and Forecast, By Application
      • 7.4.10.2. Market Size and Forecast, By End User
      • 7.4.10.3. Market Size and Forecast, By Distribution Channel
    • 7.4.11. Rest of Asia-Pacific External Nasal Dilator Market
      • 7.4.11.1. Market Size and Forecast, By Application
      • 7.4.11.2. Market Size and Forecast, By End User
      • 7.4.11.3. Market Size and Forecast, By Distribution Channel
  • 7.5. LAMEA
    • 7.5.1. Key Market Trends and Opportunities
    • 7.5.2. Market Size and Forecast, By Application
    • 7.5.3. Market Size and Forecast, By End User
    • 7.5.4. Market Size and Forecast, By Distribution Channel
    • 7.5.5. Market Size and Forecast, By Country
    • 7.5.6. Brazil External Nasal Dilator Market
      • 7.5.6.1. Market Size and Forecast, By Application
      • 7.5.6.2. Market Size and Forecast, By End User
      • 7.5.6.3. Market Size and Forecast, By Distribution Channel
    • 7.5.7. South Africa External Nasal Dilator Market
      • 7.5.7.1. Market Size and Forecast, By Application
      • 7.5.7.2. Market Size and Forecast, By End User
      • 7.5.7.3. Market Size and Forecast, By Distribution Channel
    • 7.5.8. Saudi Arabia External Nasal Dilator Market
      • 7.5.8.1. Market Size and Forecast, By Application
      • 7.5.8.2. Market Size and Forecast, By End User
      • 7.5.8.3. Market Size and Forecast, By Distribution Channel
    • 7.5.9. Rest of LAMEA External Nasal Dilator Market
      • 7.5.9.1. Market Size and Forecast, By Application
      • 7.5.9.2. Market Size and Forecast, By End User
      • 7.5.9.3. Market Size and Forecast, By Distribution Channel

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top Winning Strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

  • 9.1. GlaxoSmithKline Plc
    • 9.1.1. Company Overview
    • 9.1.2. Key Executives
    • 9.1.3. Company Snapshot
    • 9.1.4. Operating Business Segments
    • 9.1.5. Product Portfolio
    • 9.1.6. Business Performance
    • 9.1.7. Key Strategic Moves and Developments
  • 9.2. HealthRight Products LLC
    • 9.2.1. Company Overview
    • 9.2.2. Key Executives
    • 9.2.3. Company Snapshot
    • 9.2.4. Operating Business Segments
    • 9.2.5. Product Portfolio
    • 9.2.6. Business Performance
    • 9.2.7. Key Strategic Moves and Developments
  • 9.3. Zhongshan Hongze Medical Technology Co., Ltd.
    • 9.3.1. Company Overview
    • 9.3.2. Key Executives
    • 9.3.3. Company Snapshot
    • 9.3.4. Operating Business Segments
    • 9.3.5. Product Portfolio
    • 9.3.6. Business Performance
    • 9.3.7. Key Strategic Moves and Developments
  • 9.4. Permira I.P Limited
    • 9.4.1. Company Overview
    • 9.4.2. Key Executives
    • 9.4.3. Company Snapshot
    • 9.4.4. Operating Business Segments
    • 9.4.5. Product Portfolio
    • 9.4.6. Business Performance
    • 9.4.7. Key Strategic Moves and Developments
  • 9.5. Health Right Products LLC
    • 9.5.1. Company Overview
    • 9.5.2. Key Executives
    • 9.5.3. Company Snapshot
    • 9.5.4. Operating Business Segments
    • 9.5.5. Product Portfolio
    • 9.5.6. Business Performance
    • 9.5.7. Key Strategic Moves and Developments
  • 9.6. AirWare Labs
    • 9.6.1. Company Overview
    • 9.6.2. Key Executives
    • 9.6.3. Company Snapshot
    • 9.6.4. Operating Business Segments
    • 9.6.5. Product Portfolio
    • 9.6.6. Business Performance
    • 9.6.7. Key Strategic Moves and Developments
  • 9.7. Splintek Inc
    • 9.7.1. Company Overview
    • 9.7.2. Key Executives
    • 9.7.3. Company Snapshot
    • 9.7.4. Operating Business Segments
    • 9.7.5. Product Portfolio
    • 9.7.6. Business Performance
    • 9.7.7. Key Strategic Moves and Developments
  • 9.8. Scandinavian Formulas
    • 9.8.1. Company Overview
    • 9.8.2. Key Executives
    • 9.8.3. Company Snapshot
    • 9.8.4. Operating Business Segments
    • 9.8.5. Product Portfolio
    • 9.8.6. Business Performance
    • 9.8.7. Key Strategic Moves and Developments
  • 9.9. Tomed GmbH
    • 9.9.1. Company Overview
    • 9.9.2. Key Executives
    • 9.9.3. Company Snapshot
    • 9.9.4. Operating Business Segments
    • 9.9.5. Product Portfolio
    • 9.9.6. Business Performance
    • 9.9.7. Key Strategic Moves and Developments
  • 9.10. Rhinomed Limited
    • 9.10.1. Company Overview
    • 9.10.2. Key Executives
    • 9.10.3. Company Snapshot
    • 9.10.4. Operating Business Segments
    • 9.10.5. Product Portfolio
    • 9.10.6. Business Performance
    • 9.10.7. Key Strategic Moves and Developments